Fluorescent quantitative reverse transcription-polymerase chain reaction (RT-PCR) kit for detecting influenza A virus subtype H7N9

A type of influenza virus, fluorescent quantitative technology, applied in the direction of fluorescence/phosphorescence, microbial-based methods, microbial measurement/inspection, etc., can solve the problems of lack of antigens and antibodies, long cycle, high technical requirements, etc., to save reagent consumables , high specificity and sensitivity, and the effect of shortening the detection time

Active Publication Date: 2013-09-04
ZHEJIANG UNIV
View PDF1 Cites 22 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the high conditions and technical requirements for pathogen isolation and culture, and the long period; and the H7N9 subtype of influenza A virus, as a new subtype of influenza virus discovered, lacks antigens and antibodies, and there is no mature rapid diagnostic reagent on the market; real-time fluorescent quantitative PCR technology and Its fully enclosed single-t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fluorescent quantitative reverse transcription-polymerase chain reaction (RT-PCR) kit for detecting influenza A virus subtype H7N9
  • Fluorescent quantitative reverse transcription-polymerase chain reaction (RT-PCR) kit for detecting influenza A virus subtype H7N9
  • Fluorescent quantitative reverse transcription-polymerase chain reaction (RT-PCR) kit for detecting influenza A virus subtype H7N9

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0059] see figure 1 , a real-time fluorescent quantitative RT-PCR detection kit for detecting influenza A virus H7N9 subtype, which consists of quantitative RT-PCR reaction solution tube 1, enzyme mixing solution tube 2, primer-probe mixing solution tube 3, and standard product tube 4 (4 tubes in total, containing influenza A virus, H7, N9, RNase P), positive control tube 5 (4 tubes in total, containing influenza A virus, H7, N9, RNase P), negative control Tube 6 and box body 7 are formed. Quantitative RT-PCR reaction solution tube 1 is equipped with quantitative RT-PCR reaction solution, enzyme mixed solution tube 2 is equipped with enzyme mixed solution, primer-probe mixed solution tube 3 is equipped with primer-probe mixed solution, and 4 standard tubes 4 are respectively equipped with Influenza A virus, H7, N9, RNase P, 4 positive control tubes 5 are equipped with positive plasmid samples of influenza A virus, H7, N9, RNase P respectively.

[0060] Quantitative RT-PCR r...

Embodiment 2

[0063] 1 Materials and methods

[0064] 1.1 Clinical specimens and viral nucleic acids:

[0065] The clinical samples of influenza A virus and influenza A virus H7N9 subtype come from the nasopharynx of confirmed and suspected patients with influenza A virus H7N9 subtype in the First Affiliated Hospital of Zhejiang University School of Medicine and several other hospitals in Zhejiang Province Specimens such as swabs or sputum are transported to the P3 laboratory after the samples are collected. In addition, other influenza A viruses such as human seasonal H1N1, new A H1N1, human seasonal H3N2, H5N1, and influenza B virus, respiratory adenovirus, human metapneumovirus, human coronavirus-HKU1, human coronavirus- The positive nucleic acids of NL63, respiratory syncytial virus, and Boca virus were provided by the State Key Laboratory of Diagnosis and Treatment of Infectious Diseases.

[0066] 1.2 Primers and probes

[0067]Multiple gene sequences covering domestic and foreign i...

Embodiment 3

[0103] The detection of clinical samples using this kit is mainly based on the "Twelfth Five-Year Plan" major project - infectious disease pathogen detection technology platform project (2012ZX10004-210). The collected clinical samples were mainly from the First Affiliated Hospital of Zhejiang University School of Medicine and several other hospitals in Zhejiang Province between March 2013 and April 2013. A total of 1039 samples from the recent fever clinics: nasopharyngeal swab samples (971 ), sputum samples (68); a total of 143 samples from inpatients diagnosed with H7N9 in the First Affiliated Hospital of Zhejiang University School of Medicine: nasopharyngeal swab samples (95), sputum samples (48) and stool samples (10 share). The collected samples were verified by quadruple real-time fluorescent quantitative RT-PCR in this method, and the test results are as follows: 112 samples sent to the fever clinic were positive for influenza A virus, and the H7N9 subtype of influenza...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a fluorescent quantitative reverse transcription-polymerase chain reaction (RT-PCR) kit for detecting an influenza A virus subtype H7N9. The fluorescent quantitative RT-PCR kit can be used for detection of influenza A viruses and the influenza A virus subtype H7N9. The fluorescent quantitative RT-PCR kit comprises a quantitative RT-PCR reaction solution, an enzyme mixed liquor, a primer and probe mixed liquor, standard substances of influenza A viruses, H7, N9 and RNaseP, positive reference substances of influenza A viruses, H7, N9 and RNaseP), and negative reference substances. Specific primers and probes are designed according to conserved sequences of influenza A viruses, H7 and N9. The RNaseP primers and probes are used as internal references. Through the one-step quadruple real-time fluorescent RT-PCR technology, the influenza A virus and the influenza A virus subtype H7N9 in the sample can be fast and accurately detected. The fluorescent quantitative RT-PCR kit has a reasonable design, very high singularity, sensitivity and repeatability, can be used for laboratory emergency diagnosis and fast screening of an epidemic disease caused by the influenza A virus subtype H7N9, and for an epidemiology study on the influenza A virus and the influenza A virus subtype H7N9 causing fever and respiratory tract syndrome.

Description

technical field [0001] The invention belongs to the field of biological technology, and relates to a fluorescent quantitative RT-PCR detection kit, in particular to a one-step quadruple real-time fluorescent quantitative RT-PCR for detecting nasopharyngeal swabs, sputum, and nasopharyngeal aspiration of patients in the same reaction tube. The detection method of influenza A virus and influenza A virus H7N9 subtype nucleic acid in specimens such as animals can be applied to laboratory emergency diagnosis, rapid screening, clinical diagnosis and influenza A in patients with febrile respiratory syndrome caused by outbreaks of H7N9 avian influenza. Epidemiological study of influenza virus and influenza A virus H7N9 subtype. Background technique [0002] Influenza A virus H7N9 subtype is the first new subtype influenza virus discovered in the world. It was first discovered in Shanghai and Anhui in March 2013. The H7N9 subtype is a type of influenza A, which was only found in pou...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12M1/00C12Q1/70C12Q1/68G01N21/64C12R1/93
Inventor 李兰娟陈瑜谢国良崔大伟霍朝霞杨先知郑书发李雪芬
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products